Xencor | Passivo Circulante



Current Liabilities Alterar Data
AbbVie USD 36.4B 2.35B 2025-03
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amgen USD 20.48B 2.53B 2025-06
Arrowhead Research USD 194.53M 26.01M 2025-06
AstraZeneca USD 33.54B 4.41B 2025-06
Biogen USD 3.18B 2.11B 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Cytokinetics USD 131.06M 28.66M 2025-06
GlaxoSmithKline GBP 20.38B 453M 2025-06
J&J USD 56.9B 6.58B 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 26.04B 863M 2025-06
Novartis USD 31.71B 95M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Xencor USD 96.08M 7.65M 2025-06


Xencor Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.